Back

How to approach a patient with HFimpEF

18 May 2025 (14:15 - 14:30)
Organised by: Logo
Congress Presentation Part of: Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation? Treatment HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Wilfried Mullens

Hospital Oost-Limburg (ZOL), Genk (Belgium)

3 More presentations in this session

Presentation thumbnail
Broadening the scope: should we implement guideline-directed medical therapy across all left ventricular ejection fraction ranges?
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
New and emerging therapies for HFpEF
Ms K. Cerlinskaite-Bajore (Vilnius, LT)
Slides Video
Presentation thumbnail
Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation? - discussion
Video

Access the full session

Session thumbnail
Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation?
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 14:15 CET
You may be interested in
thumbnail
Congress Session
Heart failure (HF) with improved ejection fraction: how to approach a patient with HF remission
thumbnail
Congress Presentation
Can we withdraw heart failure drugs in HFimpEF, HFrecHF, and HFremEF?
thumbnail
Congress Presentation
What treatments do we have in HFimpEF, HFrecHF, and HFremEF?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources